Insightful Trader Tips
  • Finances
  • World News
  • Investing
  • Stock
Investing

Havilah Deals Uranium Assets for Equity Interest in HRE

by October 21, 2024
October 21, 2024

Havilah Resources Limited (Havilah or the Company) (ASX: HAV) is pleased to report that it has entered into binding agreements with Heavy Rare Earths Limited (ASX: HRE) relating to a portion of its extensive uranium exploration assets in the Curnamona Province of northeastern South Australia (Figure 1).

HIGHLIGHTS

Binding agreements signed with Heavy Rare Earths Limited (HRE) conferring exploration and mining rights for various high calibre uranium assets on certain of Havilah’s exploration licences (Uranium).Effectively monetises a portion of Havilah’s remaining uranium assets, providing Havilah with potentially significant uranium market exposure and uranium project development upside.

The Uranium assets include:

1. The Radium Hill project – strike extensions of the historic Radium Hill uranium mine (but not including it)1 with significant discovery potential for uranium. HRE’s exploration and mining rights also extend to rare earth elements and scandium on the Radium Hill project.

2. An unexplored 15 km section of the Billeroo palaeochannel project immediately downstream from Boss Energy Ltd’s Goulds Dam deposit.

3. A lightly explored 35 km section of the Lake Namba palaeochannel project, with numerous wide- spaced historic uranium drill intersections.

4. Prospect Hill project area representing an untested possible geological analogue to the prolific Beverley-Four Mile uranium mining camp.

Key terms of the transaction involve:

1. Issue of 38 million fully paid ordinary shares in HRE to Havilah, half of which are subject to a 6 month voluntary escrow and the other half to a 12 month voluntary escrow (Consideration Shares).

2. Grant of 17.5 million unlisted options over HRE ordinary shares, each exercisable at 6 cents within a period of 3 years from the date of issue (Consideration Options).

3. An expenditure commitment of $3 million over 3 years, with a minimum commitment of $1 million within the first year.

4. Subject to the above, an ability for HRE to earn an 80% interest in the Uranium exploration and mining rights within certain Havilah exploration licences and an 80% joint venture interest in any discovery tenements that it applies for over a Uranium discovery.

5. HRE will free carry Havilah’s 20% joint venture interest in a Uranium discovery until completion of a bankable feasibility study, following which Havilah may elect to contribute or dilute to a 1.5% NSR (net smelter return) royalty on Uranium produced.

6. Completion of the transaction and consequent issue of the ordinary shares and grant of the options to Havilah and commencement of the joint venture earn-in is subject to the following conditions precedent:

A. HRE completing due diligence, to its sole satisfaction;

B. HRE obtaining shareholder approval for the issue of the Consideration Shares and Consideration Options; and

C. The parties obtaining all other shareholder, regulatory and third-party approvals, consents or waivers which are required to complete their respective obligations under the agreements (together the Conditions Precedent).

These terms have been effected by execution of a binding Term Sheet that sets out the commercial arrangements and a binding Tenement Access and Mineral Rights Agreement that governs the access rights of HRE to Havilah’s relevant exploration licences.

After this transaction with HRE and the earlier transaction with Koba Resources Limited (refer to ASX announcement 22 January 2024), Havilah still retains 100% ownership of several promising hard rock prospects including the Johnson Dam prospect (refer to ASX announcement 17 May 2023), the Homestead prospect (refer to ASX announcement 29 August 2023), the Birksgate prospect (refer to ASX announcement 15 January 2024) and the Coolibah palaeochannel.

Click here for the full ASX Release

This post appeared first on investingnews.com
previous post
Australian lawmaker confronts British royals: ‘You are not my king’
next post
InhaleRx Secures $38,500,000 Funding to Fully Fund Clinical Development Plans

Related Posts

Finlay Minerals Announces Closing of Non-Brokered Private Placement...

June 10, 2025

China Eases Rare Earths Grip, Grants US, EU...

June 10, 2025

Drilling Planned to Update & Grow Lo Herma...

June 10, 2025

Sarama Outlines Extensive Gold Trends at Cosmo Gold...

June 10, 2025

More high-grade assays pave way for resource at...

June 10, 2025

Mario Innecco: Gold Still in Third Inning, When...

June 9, 2025

Walker Lane Resources Ltd. Receives TSX Approval for...

June 9, 2025

Tech 5: CoreWeave and Applied Digital Strike Deal,...

June 9, 2025

Crypto Market Recap: Bitcoin Funds Hit US$7 Billion,...

June 9, 2025

Empire Metals Limited Announces Exceptional High-Purity TiO2 Product...

June 9, 2025

Investing

  • Finlay Minerals Announces Closing of Non-Brokered Private Placement of Flow-Through Shares and Non-Flow-Through Units

    June 10, 2025
  • China Eases Rare Earths Grip, Grants US, EU Auto Giants Fast Track Licenses

    June 10, 2025
  • Drilling Planned to Update & Grow Lo Herma Resource

    June 10, 2025
  • Sarama Outlines Extensive Gold Trends at Cosmo Gold Project

    June 10, 2025
  • More high-grade assays pave way for resource at Golden Eye

    June 10, 2025

Disclaimer: InsightfulTraderTips.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InsightfulTraderTips.com All Rights Reserved.

    Insightful Trader Tips
    • Finances
    • World News
    • Investing
    • Stock
    Insightful Trader Tips
    • Finances
    • World News
    • Investing
    • Stock
    Copyright © 2025 InsightfulTraderTips.com All Rights Reserved.